SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-058044
Filing Date
2021-04-30
Accepted
2021-04-30 06:10:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2111568d3_defa14a.htm DEFA14A 16705
2 GRAPHIC tm2111568d3_def14faimg01.jpg GRAPHIC 508357
3 GRAPHIC tm2111568d3_def14faimg02.jpg GRAPHIC 323446
  Complete submission text file 0001104659-21-058044.txt   1163475
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38128 | Film No.: 21873576
SIC: 2834 Pharmaceutical Preparations